World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
46299
World Ranking
7267
National Ranking
275

Overview

Suresh Senan is affiliated with the University of Amsterdam in the Netherlands, focusing on medical research with specific expertise in oncology and radiotherapy. They have contributed extensively to the field of pulmonary and respiratory medicine as well as related subfields such as radiology, nuclear medicine and imaging, radiation, and surgery. Their scholarly output amounts to over 360 publications predominantly centered on medicine.

The scientist's primary research interests encompass topics relevant to lung cancer diagnosis and treatment, as well as advanced radiotherapy techniques. They also work on lung cancer treatments and mutations, medical imaging techniques and applications, cancer immunotherapy and biomarkers, radiomics and machine learning in medical imaging, and lung cancer research studies.

Frequent publication venues for Suresh Senan include:

  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Thoracic Oncology
  • Annals of Oncology
  • Lung Cancer

Suresh Senan has collaborated repeatedly with several coauthors, notably Famke L. Schneiders, Idris Bahce, Ben J. Slotman, Chris Dickhoff, and M. Palacios. These collaborations reflect sustained partnerships contributing to a significant number of publications in oncology and radiation therapy.

Among the recent papers associated with Senan's network of research or topics of interest are:

  • Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial, 2020, Journal of Clinical Oncology
  • Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial, 2021, Journal of Thoracic Oncology
  • Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus, 2020, Annals of Oncology
  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement, 2020, Radiotherapy and Oncology
  • Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial, 2020, Annals of Oncology

Best Publications

  • Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †

    S Novello;F Barlesi;R Califano;R Califano;T Cufer

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim

  • Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

    David A Palma;Robert Olson;Stephen Harrow;Stewart Gaede

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

    Berend J Slotman;Corinne Faivre-Finn;Gijs Kramer;Elaine M Rankin

  • Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial.

    David A. Palma;Robert Olson;Stephen Harrow;Stewart Gaede

  • Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.

    David A. Palma;Suresh Senan;Kayoko Tsujino;Robert B. Barriger

  • Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer

    Frank J. Lagerwaard;Cornelis J.A. Haasbeek;Egbert F. Smit;Ben J. Slotman

  • Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

    Ben J Slotman;Harm van Tinteren;John O Praag;Joost L Knegjens

  • Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

    Tom Treasure;Loic Lang-Lazdunski;David Waller;Judith M Bliss

  • Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.

    Wilko F.A.R. Verbakel;Johan P. Cuijpers;Daan Hoffmans;Michael Bieker

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis

    David Palma;Otto Visser;Frank J. Lagerwaard;Jose Belderbos

  • Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: A retrospective analysis

    Sashendra Senthi;Frank J Lagerwaard;Cornelis J A Haasbeek;Ben J Slotman

  • PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer

    Suresh Senan;Anthony Brade;Lu Hua Wang;Johan Vansteenkiste

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

    Allison B. Ashworth;Suresh Senan;David A. Palma;Marc Riquet

  • Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.

    Cécile Le Péchoux;Ariane Dunant;Suresh Senan;Aaron Wolfson

  • Outcomes of Stereotactic Ablative Radiotherapy in Patients With Potentially Operable Stage I Non-Small Cell Lung Cancer

    Frank J. Lagerwaard;Naomi E. Verstegen;Cornelis J.A. Haasbeek;Ben J. Slotman

  • Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer

    René W.M. Underberg;Frank J. Lagerwaard;Ben J. Slotman;Johan P. Cuijpers

Frequent Co-Authors

Ben J. Slotman
Ben J. Slotman University of Amsterdam
Egbert F. Smit
Egbert F. Smit VU University Medical Center
Dirk De Ruysscher
Dirk De Ruysscher Maastricht University
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid
Pieter E. Postmus
Pieter E. Postmus Leiden University Medical Center
Cécile Le Péchoux
Cécile Le Péchoux Institut Gustave Roussy
Everett E. Vokes
Everett E. Vokes University of Chicago
Lawrence B. Marks
Lawrence B. Marks University of North Carolina at Chapel Hill
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering medical study in the USA opens doors to a wide range of online degree options and career upgrades. Many healthcare professionals extend their expertise through flexible programs tailored for working adults. For those focused on healthcare management, accredited mha programs provide essential leadership and administrative skills needed to advance in hospital and clinical settings.

Registered nurses seeking to boost their credentials can enroll in rn to bsn online no clinicals accredited degrees, allowing them to complete their bachelor’s studies without onsite clinical requirements.

For advanced practice nurses, accelerated msn to dnp programs enable fast-track doctoral study, often entirely online. Those looking for efficiency can also explore the shortest dnp program options, making it easier to achieve top clinical or leadership roles without extended time away from work. These pathways help medical professionals flexibly reach career milestones, staying competitive in a rapidly evolving healthcare landscape.

Best Scientists Citing Suresh Senan

Trending Scientists

Recently Published Articles